Mutations in SLC34A2 are associated with pulmonary alveolar microlithiasis [55], and recently, dysregulation of NaPi-IIb has been implicated in tumorigenesis and progression of non-small cell lung cancer [66]. This evidence concerns the gene SLC34A2 and non-small cell lung carcinoma.